Skip to main content
. 2021 Mar 19;13(3):184–190. doi: 10.14740/jocmr4452

Table 3. ICU Interventions, Peak Laboratory Values and Outcomes in COVID-19 Patients.

Interventions All (n) Alive n (%) Died n (%) P value Odds ratio
N 1,204 734 (61) 470 (39) < 0.05
Mechanical ventilation 713 340 (46) 373 (79) < 0.05 0.22 (0.12 - 0.29)
  Duration 7 ± 13 7 ± 9 0.44
BiPAP 399 212 (29) 187 (40) < 0.05 0.62 (0.48 - 0.79)
  Duration 1 ± 3 1 ± 3 0.12
ECMO 27 16 (2%) 11 (2) 0.85 0.93 (0.43 - 2.01)
  Duration 1 ± 0.1 1 ± 0.15 0.85
Nitric oxide 2 1 (0.1) 1 (0.2) 0.75 0.64 (0.40 - 10.25)
HFNC 573 370 (50) 203 (43) < 0.05 1.33 (1.05 - 1.68)
Flolan 97 26 (3.5) 71 (15) < 0.05 0.20 (0.13 - 0.32)
Medications
  HCQ 476 265 (56) 211 (44) < 0.05 1.44 (1.13 - 1.82)
    Duration 2 ± 3 2 ± 3 0.17
  TCZ 272 162 (60) 110 (40) 0.64 0.93 (0.70 - 1.22)
    Duration 0.3 ± 0.6 0.3 ± 0.6 0.29
  Remdesivir 162 105 (65) 57 (35) 0.32 1.21 (0.86 - 1.71)
    Duration 1 ± 2 1 ± 2 0.29
  Steroids 602 357 (59) 245 (41) 0.26 0.87 (0.69 - 1.09)
    Duration 4 ± 6 4 ± 6 0.84
Laboratory values
  D-dimer peak 5,912 4,483 7,342 < 0.05
  Ferritin peak 3,942 1,953 5,931 < 0.05
  LDH peak 782 567 998 < 0.05
  CRP peak 22 20 24 < 0.05
  ESR peak 65 68 62 0.46
Outcomes
  Comfort care 136 11 (2) 125 (26) < 0.05 0.04 (0.02 - 0.07)
  Hospital LOS 18 ± 16 12 ± 10 < 0.05
  ICU LOS 9 ± 12 8 ± 9 0.08
Discharge location 716
  Inpatient rehabilitation 295 (42)
  SNF 212 (30)
  Home/NH 137 (19)
  Hospice 56 (8)
  AMA 8 (1)

ICU: intensive care unit; BiPAP: bilevel positive airway pressure; ECMO: extracorporeal membrane oxygenation; HFNC: high-flow nasal cannula; HCQ: hydroxychloroquine; TCZ: tocilizumab; LOS: length of stay; LDH: lactate dehydrogenase; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; SNF: skilled nursing facility; NH: nursing home; AMA: against medical advice.